AMRA® Official (@AMRAMedical) header
AMRA® Official (@AMRAMedical) profile picture

A new global standard in body composition assessment offers multiple fat & muscle biomarkers with unrivaled precision & accuracy, from a rapid, whole-body MRI

Linköping, Sweden
Joined September 2015
Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)Photo by AMRA® Official (@AMRAMedical)
How do we bridge the gap between AI innovation and clinical application? AI and Image Analysis Expert Iulian Emil Tampu, PhD are joining international leaders and policy makers to discuss the future of AI in healthcare and life sciences at Sweden–Singapore AI Outlook Days 2026
1
42
Beyond BMI: What can detailed body composition reveal about metabolic health in children? Join AMRA this Saturday at #ObesityWeek2026 from 7:30-8:30pm to learn more about recent research findings. Read more: eu1.hubs.ly/H0zR4sK0
1
56
We’re pleased to announce our partnership with #Voiant, bringing together #AMRAMedical’s validated quantitative MRI-based body composition biomarkers and Voiant’s advanced clinical trial imaging capabilities. Read the full announcement: eu1.hubs.ly/H0zQQ7p0
31
Our Insights in Brief article, explores findings from a secondary analysis of the Phase 3b STEP UP trial. AMRA® Researcher was used to characterize changes in adipose tissue, skeletal muscle volume and muscle fat infiltration during semaglutide treatment. eu1.hubs.ly/H0zPcj50
31
Live from AASLD’s The Liver Meeting 2026 in Denver! #AMRAMedical is contributing to four posters exploring how MRI-derived muscle measurements can provide deeper insights into muscle health in chronic liver disease and cirrhosis. Read more: eu1.hubs.ly/H0zG3kz0 #TLM26
76
Missed our recent presentation at #EASD2026? Watch AMRA’s Chief Scientific Officer Dr. Jennifer Linge present “COURAGE Body Composition: Muscle Composition Assessed by MRI”. ▶️ View Dr. Linge’s presentation here: easd.org/media-centre/#/sess… #GLP1 #MuscleComposition #AMRAMedical
1
53
We’re heading to #TLM26! AMRA is contributing to 4 studies exploring MRI-derived muscle health measures in liver disease, and their associations with long-term outcomes, post-transplant hospital burden, frailty & neurocognitive function. Connect with us: eu1.hubs.ly/H0zqz8P0
1
41
Tomorrow at the #ObesityDrugDevelopment Europe, #AMRA CSO Dr. Jennifer Linge will explore how MRI biomarkers can characterize muscle changes during weight loss, highlighting the value of looking beyond body weight alone during weight-management treatment.
🤖 Made with AI
38
A new analysis of Novo Nordisk’s STEP UP trial used AMRA® Researcher to look beyond weight loss, examining changes in muscle volume, muscle fat infiltration and adipose tissue during semaglutide-induced weight loss. Discover more: eu1.hubs.ly/H0zdpnS0
24
Strong discussions at #EASD2026 on the importance of looking beyond weight loss to better understand changes in muscle during #obesity treatment! Explore #AMRA’s quantitative MRI technology, enabling deeper insight into muscle and fat in metabolic trials: tinyurl.com/3xzj5zpf
40
AMRA is presenting TODAY at #EASD2026! Dr. Jennifer Linge will present “COURAGE Body Composition: Muscle Composition Assessed by MRI,” as part of the symposium “Preserving muscle during GLP-1 RA treatment: insights from the trevogrumab COURAGE study.” tinyurl.com/d7vumvjy
50
Today, Team £AMRA is joining the FSHD Society’s Walk & Roll to Cure FSHD! Members of our team are walking alongside the FSHD community in two U.S. cities: 📍 St. Louis, MO — September 26 📍 Worcester, MA — September 27 Come find us and say hello! #FSHD #WalkAndRoll
92
New insights into muscle during GLP-1 RA treatment at #EASD2026. #AMRAMedical CSO Dr. Jennifer Linge presents COURAGE Body Composition: Muscle Composition Assessed by MRI on Oct. 1. 🕒 17:30–18:30 CEST 📍 Vienna Hall, Milan Learn more: amramedical.com/events/easd-…
🤖 Made with AI
60
We’re proud to share: AMRA Medical has once again been named one of the world’s leading HealthTech companies by TIME and Statista — this year earning an Outstanding ranking, the highest distinction, in the Diagnostics category. Read: tinyurl.com/36em4a5w
37
We’re pleased to announce an investment from HealthCap, one of Europe’s leading life science venture capital firms. The investment will support AMRA’s continued product innovation and international expansion Read more: tinyurl.com/2a7kepj3 #AMRAMedical #MRI #HealthTech
35
Featured on the cover of Neurology. New research using AMRA® Researcher published in Neurology as “Muscle MRI as an imaging biomarker of muscle damage in patients with spinal and bulbar muscular atrophy”. Read the Press Release here: tinyurl.com/5288std5 #AMRAMedical
1
119
Day One of the 4th Annual Obesity & Weight Loss Drug Development Summit. AMRA's CEO Olof Dahlqvist Leinhard presenting, "Reshaping the Standard: MRI Muscle Composition for Treatment Evaluation in Metabolic Disease and Beyond."
1
51
During this year's ICNMD 2026 congress, AMRA will present a poster featuring findings from the ReDUX4 Open-Label Extension study, exploring how quantitative whole-body MRI can provide sensitive, objective biomarkers for use in Facioscapulohumeral Muscular Dystrophy (FSHD) trials.
90
AMRA Medical is a proud sponsor of the 33rd International Research Congress on FSHD (IRC on FSHD), taking place June 25-26! Will you be attending IRC 2026? We would love to connect! Reach out to [email protected]
78
Today, June 20th, marks World FSHD Day 🍊 Across our AMRA family worldwide, we’re showing our support for the FSHD community today with a simple orange-slice smile! #WorldFSHDDay #FSHD #CureFSHD #FacesOfFSHD #AMRAMedical
2
41